CYC vs HIQ

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

41LOW

HIQ

HITIQLTD FPO [HIQ]

41LOW

Score Breakdown

CYC HIQ
Technical
41
75
Catalyst
51
69
Sentiment
50
50
Fundamental
69
50
Momentum
39
44
Risk Gate
50
24

Key Metrics

CYC Metric HIQ
$61.6MMarket Cap$9.3M
345KAvg Volume (20d)2.9M
N/AShort InterestN/A
$1.29052-Week High$0.040
$0.45052-Week Low$0.004
-6.7%Daily Change+0.0%
$0.490Entry Price$0.010
-49.3%ROEN/A
-53.3%Profit MarginN/A

Active Signals

CYC Signals

●RSI drifting toward oversold territory — worth watching
●Volume surging at 2.7x normal while price falls — heavy selling pressure
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (1.9x)
●Moderate revenue growth (+10%)
●EPS estimates revised upward (+10pts)

HIQ Signals

●MACD momentum is picking up steam
●Volume surging at 3.2x normal while price climbs — real buying conviction behind this move
●On a tear — up 66.7% over the last 5 days
●Beating the Small Ords index — relative strength of 1.19, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.3 quarters)
●Low P/S ratio (4.7x)
●Piotroski F-Score weak (1/9, low-confidence approx)

Ask Scout AI to compare CYC and HIQ in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CYC Full Analysis → HIQ Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).